Tirzepatide Description
Tirzepatide is a dual incretin agonist that activates both GIP and GLP-1 receptors to enhance satiety, slow gastric emptying, and improve insulin secretion and sensitivity. Its dual-pathway mechanism supports substantial weight loss and glycemic improvements alongside diet and activity changes.
Benefits of Tirzepatide
- Powerful appetite control and increased fullness
- Supports substantial weight loss with lifestyle changes
- Improves insulin sensitivity and glucose regulation
- May reduce A1C in adults with type 2 diabetes
- Broad cardiometabolic support
